Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Itraconazole → Malic Acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Itraconazole | HCID 55283 | — |
| 반응물 | L-Malic Acid | HCID 222656 | — |
| 반응물 | cis-itraconazole L-tartaric acid | HCID 131728781 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | Malic Acid | HCID 525 | — |
| 생성물 | Itraconazole | HCID 55283 | — |
| 생성물 | L-Malic Acid | HCID 222656 | — |
반응 단계
Co-crystals of itraconazole and malic acid were prepared. To prepare the L-malic acid co-crystal salt of cis-itraconazole, 100.4 mg of cis-itraconazole free base, 0.50 mL of THF, and a magnetic stir bar were charged into a screw cap vial. A solution of 191.3 mg of L(−)malic acid in 5.0 mL of THF was prepared. 0.50 mL of the L-malic acid solution was added to the vial containing cis-itraconazole and the solution was heated with a heat gun to dissolve. The solution was allowed to cool and was then seeded with <1 mg of the salt from cis-itraconazole-L-tartaric acid co-crystal. The cooled crystals were filtered in a centrifuge filter tube. The filter cake was broken-up and allowed to air-dry prior to analysis. (See FIGS. 18 and 19)
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07927613B2 |
| 출처 데이터셋 | uspto-grants-2011_04 |
| ORD ID | ord-6fc3c7a2d0c14917a244ca35d1dc3421 |
| 출처 메모 | uspto-grants-2011_04 |